Giffin Brett A.'s Form 4/A amendment
AmendedT2 Biosystems, Inc. (TTOO) · filed Nov 28, 2023
- Accession no.
- 0000950170-23-066386
- Filed
- Nov 28, 2023
- Trade date
- Feb 20, 2023
- Filing delay
- 281 days
- Rule 10b5-1 plan
- Not checked
- Original filed
- Mar 9, 2023
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $349.05. It was filed 281 days after the trade.
This amendment replaces 0000899243-23-007727 (filed Mar 9, 2023).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Giffin Brett A.CIK 0001892921 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 20, 2023 | Common Stock | MOption exerciseAcquired | +1,333 | –F1 | – | 3,586 | Direct | |
| Feb 20, 2023 | Common Stock | SSaleDisposed | −537 | $0.65 | −$349.05 | 3,049 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 20, 2023 | Common Stock | MOption exerciseDisposed | −1,333 | $0.00 | $0 | 2,667 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Referenced by the price of 1 transaction in Table I.
- F2
The original Form 4 filed on March 9, 2023 is amended by this Form 4 amendment to correct the amount of securities beneficially owned following the reported transactions.
- F3
The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person adopted by the reporting person on November 10, 2021.
- F4
On February 20, 2022 the reporting person was granted 4,000 RSU's that vest in three equal annual installments commencing on February 20, 2023.